For most patients, this side effect is mild to moderate in severity and tends to resolve within several weeks as the body adjusts to the medication
Here, we have a unique opportunity to embrace GLP-1 agonists, not as shortcuts or quick fixes, but as a means of creating the conditions that allow overweight people to succeed in making lifestyle changes where they have previously failed
Antiatherogenic effects of liraglutide in hyperglycemic apolipoprotein E-null mice via AMP-activated protein kinase-independent mechanisms
Induction of erythrocyte membrane blebbing by methotrexate-induced oxidative stress
Together, these two incretins contribute to metabolic homeostasis, preventing both hyperglycemia and hypoglycemia, mitigating dyslipidemia, and reducing the risk of cardiovascular diseases in individuals with type 2 diabetes and obesity